GTP-Dependent K-Ras Dimerization  by Muratcioglu, Serena et al.
ArticleGTP-Dependent K-Ras DimerizationGraphical AbstractHighlightsd The GTP-bound K-Ras4B catalytic domain can form stable
homodimers
d The K-Ras4B predicted b-sheet dimer interface overlaps the
effectors’ binding site
d The K-Ras4B a3/a4 helical dimer interface may promote Raf
dimerization
d The two interfaces may illuminate K-Ras4B nanocluster
formationMuratcioglu et al., 2015, Structure 23, 1325–1335
July 7, 2015 ª2015 Elsevier Ltd All rights reserved
http://dx.doi.org/10.1016/j.str.2015.04.019Authors
Serena Muratcioglu,
Tanmay S. Chavan,
Benjamin C. Freed, ...,
Nadya I. Tarasova, Vadim Gaponenko,
Ruth Nussinov
Correspondence
nussinor@helix.nih.gov (R.N.),
vadimg@uic.edu (V.G.)
In Brief
Muratcioglu et al. show that GTP-bound
but not GDP-bound K-Ras4B catalytic
domain can form stable homodimers.
Modeling reveals two major dimer
interfaces. The highly populated b-sheet
interface is at the Switch I/effector
binding regions. The second major
dimerization mode involves helical
interfaces at the C-terminal allosteric lobe
of the G domain.
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Ras proteins recruit and activate effectors, including
Raf, that transmit receptor-initiated signals. Mono-
meric Ras can bind Raf; however, activation of Raf
requires its dimerization. It has been suspected
that dimeric Ras may promote dimerization and
activation of Raf. Here, we show that the GTP-
bound catalytic domain of K-Ras4B, a highly onco-
genic splice variant of the K-Ras isoform, forms
stable homodimers. We observe two major dimer in-
terfaces. The first, highly populated b-sheet dimer
interface is at the Switch I and effector binding re-
gions, overlapping the binding surfaces of Raf,
PI3K, RalGDS, and additional effectors. This inter-
face has to be inhibitory to such effectors. The
second, helical interface also overlaps the binding
sites of some effectors. This interface may promote
activation of Raf. Our data reveal how Ras self-
association can regulate effector binding and activ-
ity, and suggest that disruption of the helical dimer
interface by drugs may abate Raf signaling in
cancer.
INTRODUCTION
Ras-family proteins are small membrane-associated guanosine
triphosphatases (GTPases). Acting as molecular switches in
response to receptor-mediated extracellular signals, they regu-
late cell survival, proliferation, motility, and cytoskeletal organi-
zation (Karnoub and Weinberg, 2008; Stephen et al., 2014).
Ras-guanosine triphosphate (GTP) activates downstream effec-
tors, including Raf kinase (Brennan et al., 2011; Rajakulendran
et al., 2009) and phosphatidylinositol 3-kinase (PI3K) (Castellano
and Downward, 2011; Castellano et al., 2013; Mitin et al., 2005;
Repasky et al., 2004). Signal-activated Ras recruits Raf to the
cell membrane and activates its kinase domain. Activation re-Structure 23, 1quires Ras binding, which opens the closed Raf conformation,
thereby allosterically altering the kinase domain and promoting
its dimerization (Lavoie et al., 2013). Raf side-to-side dimer for-
mation (Rajakulendran et al., 2009) is necessary for normal
Ras-dependent Raf kinase activation (Freeman et al., 2013).
Dimerization also takes place in disease-associated constitu-
tively active mutant Raf proteins and in inhibitor-induced Raf
activation (Lavoie et al., 2013; Tsai andNussinov, 2014). Through
phosphorylation, active Raf triggers theMEK and ERK protein ki-
nases, resulting in cell proliferation and survival (Nussinov, 2013;
Rajakulendran et al., 2009). The crystal structure of Ras in com-
plex with the Raf Ras-binding domain (RBD) (PDB: 4G0N)
indicates that the high-affinity Raf-Ras interaction involves
extension of the Ras b sheet at the Ras-effector binding region
(Fetics et al., 2015). Early studies suggested that Raf dimeriza-
tion is induced downstream by the dimeric 14-3-3 cofactor pro-
tein (Tzivion et al., 1998). However, a recent observation that
C-Raf forms dimers, trimers, and tetramers in the presence of
Ras-GTP argues that Ras plays a significant role in Raf dimeriza-
tion (Nan et al., 2013). How Ras promotes dimerization of Raf is
unknown. A plausible hypothesis that Ras dimerization assists in
self-association of Raf (Inouye et al., 2000) is gaining significant
attention, leading to an overarching community goal to validate
and understand Ras dimerization and how it relates to regulation
activation and inhibition of Raf (Santos, 2014; Thompson, 2013).
All three Ras isoforms, including H-Ras (Harvey sarcoma viral
oncogene), N-Ras (neuroblastoma oncogene), and K-Ras (Kirs-
ten sarcoma viral oncogene), with splice variants K-Ras4A and
K-Ras4B, activate Raf to varying degrees. K-Ras, which is
frequently mutated in human cancer (Lawrence et al., 2014), is
the most potent activator of Raf among Ras isoforms (Prior
et al., 2012). The reason for the differential activity of Ras pro-
teins toward Raf is unclear. One possible reason may relate to
differences in the dimeric structures of Ras isoforms and the dif-
ferential ways through which they associate with raft/non-raft re-
gions in the cell membrane (Jang et al., 2015). The sequences
and structures of the catalytic domains (G domains) of Ras
isoforms are almost identical, but differ significantly in the 22-
residue long C-terminal hypervariable region (HVR), which is
lysine-rich in K-Ras4B (Hancock et al., 1990) (Figure 1). There325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1325
Figure 1. K-Ras4B Sequence and Structure
(A) The sequence of the K-Ras4B protein. In the
sequence, hydrophobic, polar/glycine, positively
charged, and negatively charged residues are
colored black, green, blue, and red, respectively.
Underlined residues denote hypervariable region
(HVR).
(B) Connection of each domain in K-Ras4B protein.
(C) A crystal structure of K-Ras4B protein in the
GTP-bound state (PDB: 3GFT). The structure was
generated for wild-type sequence modified from
the crystallized mutant conformation. Functional
regions are marked on the structure.are more than 130 crystal structures of the Ras catalytic domain
(Rose et al., 2015); the majority present Ras as a functional
monomer. The HVR is invariably missing due to its high flexibility.
Recent studies suggest that N-Ras-guanosine diphosphate
(GDP) can form dimers in a model membrane (Guldenhaupt
et al., 2012). Native H-Ras can dimerize on membrane surfaces,
and the Switch II region (residues 60–76) plays a role in dimer for-
mation (Lin et al., 2014). While mechanistic details of H-Ras and
N-Ras dimerization are emerging, how K-Ras dimerizes and how
Ras dimerization relates to activation of its effectors are still
unclear.
Here, we show that GTP-bound, but not GDP-bound
K-Ras4B catalytic domain, is capable of forming stable homo-
dimers. Modeling of the GTP-bound structure reveals two
major dimer interfaces. Using dynamic light scattering (DLS),
isothermal titration calorimetry (ITC), microscale thermophore-
sis (MST), fluorescence spectroscopy, Fo¨rster resonance en-
ergy transfer (FRET), and nuclear magnetic resonance (NMR),
we test and confirm the modeled structures. Importantly, the
first highly populated dimer interface spans the Switch I and
effector binding regions at the effector lobe. It involves b-sheet1326 Structure 23, 1325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reservedextension and is very similar to the Raf
interaction as well as to other effectors
binding at this surface. In the second
major dimerization mode, the interaction
involves helical interfaces at the C-termi-
nal allosteric lobe of the G domain.
These results not only validate the ability
of Ras catalytic domain to form dimers,
but also suggest that dimer formation
provides a previously unknown mecha-
nism for how possible Ras dimers may
regulate dimerization and signaling out-
puts of Raf. They suggest that under
certain conditions RBDs of Ras effectors
and regulators compete with the b-sheet
dimer interface of K-Ras4B. At the same
time, Raf dimerization can be promoted
by Ras dimerization through the helical
interface. Our results point to the com-
plex mechanisms of signaling regulation
through dynamic Ras oligomerization. In
addition, they argue that targeting the
helical interfaces via orthosteric or allo-steric inhibitors may provide therapeutic intervention targeting
the dimerization of Raf.
RESULTS
The GTP-Bound but Not GDP-Bound K-Ras Catalytic
Domain Forms Stable Dimers
To evaluate the oligomerization state of K-Ras G domain, we
performed DLS experiments. DLS of GDP-bound K-Ras4B1–166
showed a broad size distribution of protein particles (Figure 2A).
The predominant species has a radius that corresponds to a
globular protein of 18 kDa molecular mass (see numerical data
for K-Ras4B in Table 1), which is similar to the mass of a
G-domain monomer (18.8 kDa for K-Ras4B1–166). In contrast,
K-Ras4B1–166 freshly loaded with GTP-g-S (guanosine 5
0-O-
[g-thio]triphosphate) exhibits a narrow particle size distribution
(with 9.9% polydispersity) and a radius that corresponds to a
globular protein with a molecular mass of 41 kDa. Although the
experiment was performed in the presence of high concentration
of reducing agent, we analyzed the samples by high-resolution
mass spectrometry to further confirm the absence of a covalent
Figure 2. Dynamic Light Scattering Demonstrates Nucleotide-
Dependent Oligomerization of K-Ras4B
(A) Dynamic light scattering (DLS) shows formation of a stable dimer (41 kDa)
by an active GTP-g-S-loaded K-Ras4B G domain but not by inactive GDP-
loaded (18 kDa) or GppNHp-loaded (21 kDa) protein.
(B) DLS suggests formation of a loose dimer by the full-length K-Ras4B1–188-
GDP (38 kDa) and a tetramer by K-Ras4B1–188-GTP-g-S (74 kDa).
Table 1. Numerical Data for Different Forms of K-Ras4B
Sample
Radius
(nm) % Polydispersity
Mw-R
(kDa) % Intensity
K-Ras4B1–166-
GTP-g-S (25 mM)
2.9 9.9 41 98.1
K-Ras4B1–166-
GDP (83 mM)
2.0 37.5 18 99.9
K-Ras4B1–166-
GppNHp (83 mM)
2.17 9.5 21 88
K-Ras4B1–188-
GTP-g-S (9.8 mM)
3.7 33.0 74 99.8
K-Ras4B1–188-
GDP (21 mM)
2.8 9.7 38 99.7
Mw-R is the estimated mass based on the determined hydrodynamic
radius and particle density for the globular protein model.dimer that could be formed through oxidation of cysteine resi-
dues. The data suggest that K-Ras4B1–166-GTP-g-S forms a sta-
ble non-covalent dimer, while K-Ras4B1–166-GDP may have a
reduced tendency to self-associate. It is remarkable that the G
domain loaded with the most commonly used GTP analog, gua-
nosine 50-[b,g-imido]triphosphate (GppNHp), is a predominantly
monomeric 21-kDa protein as observed from available crystal
structures. Full-length K-Ras4B demonstrated dimer formation
in the GDP-bound form, while the GTP-g-S protein had a radius
corresponding to a tetramer with large polydispersity (Figure 2B;
Table 1).
Predictions of K-Ras4B Dimer Structures
To evaluate the structural basis for dimer formation by Ras pro-
teins, we exploited a powerful template-based protein-protein
complex structure prediction algorithm (PRISM) (Acuner Ozba-
bacan et al., 2012; Aytuna et al., 2005; Kar et al., 2012; OgmenStructure 23, 1et al., 2005; Tuncbag et al., 2011, 2012). The list of target PDB
codes used for the predictions is provided in Table S1. Our
modeling results suggest that in both GTP- and GDP-bound
states, K-Ras4B1–180 can form homodimers through the same
interface (Figure 3A; Figure S1). In both cases, the interface re-
gions include a1, b2, and b3. However, the K-Ras4B-GTP homo-
dimer is more stable than its GDP counterpart. The enhanced
stability is associated with a larger interface and more hot spots
(see the Experimental Procedures) in the GTP-bound homo-
dimer and, thus, greater favored binding energy score (BES).
Analysis of atomic interactions showed that the Ras-GTP homo-
dimer interface contains more H bonds than the GDP-bound
homodimer (Tables S2–S5). To corroborate the predicted inter-
face, we reconstructed all possible crystal dimer interfaces of
Ras structures using the Evolutionary Protein-Protein Interface
Classifier (EPPIC) (Duarte et al., 2012) server. One of the crystal
interfaces of the Ras dimer is similar to our predicted K-Ras4B-
GTP homodimer and even H-Ras-GTP dimer interfaces (Figures
S2A–S2C). To evaluate the structural similarity between the crys-
tal and predicted dimer interfaces, we aligned the interface re-
gions and calculated the interface root-mean-square deviation
(RMSD) using the backbone atoms. The superimposed struc-
tures are shown in Figures S2D–S2G. The interface RMSD of
crystal-H-Ras-GTP and crystal-K-Ras4B-GTP aligned struc-
tures are 5.62 and 5.06 A˚, respectively. Most of the residues
that are predicted to participate in the dimerization interface
also reside at the crystal interface. Residues such as Q25 and
Y40 are shared by both crystal and predicted K-Ras4B-GTP in-
teractions and are part of the critical region of the interface site.
The first major predicted K-Ras4B-GTP dimer interface involves
a (shifted) b-sheet extension, forming intermolecular H bonds
between b2 strands (hereafter referred to as b homodimer).
Computations also predict a helical dimer interface involving he-
lices a3 and a4 (hereafter referred as a homodimer) (Figure 3B;
Table S6). We also observed two minor interfaces: a (helices
a4 and a5) and b (exact alignment of the b2 strands) (Figure S3).
We further predicted that GTP-bound Ras can bind GDP-bound
Ras through these interface regions with differing stabilities (Fig-
ure S4; Table S7); however, the most favorable interface (heter-
odimer 1) remarkably overlaps with the major one predicted for
the GTP- and GDP-bound homodimers, involving a shifted
b-sheet extension.325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1327
Figure 3. Predicted Major Homodimer Structures of Active Ras Isomer
(A) Predicted homodimer structure of GTP-bound K-Ras4B1–180 with a shifted b-sheet extension (b homodimer; PDB: 4DSO). Binding energy score (BES) for the
prediction is 44.53 (template interface: 2erxAB). Interface residues are I21, I24, Q25, H27, V29, E31, D33, I36, E37, D38, S39, Y40, R41, K42, Q43, and L52.
A minor b-sheet homodimer structure of K-Ras4B1–180-GTP with an exact sheet-alignment is shown in Figure S3A.
(B) Predicted homodimer structure of GTP-bound K-Ras4B1–167 with the interface involving helices a3 and a4 (a homodimer; PDB: 3GFT). Dimer interface is found
to be at the allosteric lobe with BES of 17.92 (template interface: 4a9eAB). Interface residues are E91, H94, R97, E98, K101, R102, D105, S106, E107, Q129,
D132, L133, R135, and S136. A minor helical homodimer structure of K-Ras4B1–167-GTP with the interface involving helices a4 and a5 is shown in Figure S3B.Biophysics of K-Ras4B Dimers
Because of the structural complexity and heterogeneity of Ras
oligomerization, we limited our initial biophysical studies to the
Ras catalytic domain. The observed tetramer formation by full-
length K-Ras even in the absence of the membrane anchoring
is in good agreement with the previously observed self-associa-
tion of K-Ras4B HVR domain (Jang et al., 2015), suggesting that
the HVR can contribute further to stabilization of Ras oligomeric
structures. Themechanisms of the catalytic domain dimerization
are important due to their involvement in regulation of Ras
signaling. To characterize the stability of the G-domain dimer,
we performed ITC studies on K-Ras4B1–166-GTP-g-S. A 30-mM
solution of the freshly GTP-g-S-loaded protein was titrated into
the instrument’s cell that contained the buffer used for gel filtra-
tion of the protein sample. Dissociation of the dimer was accom-
panied by an enthalpy change allowing the determination of the
apparent dissociation constant of the dimer, KD = 770 ± 200 nM
(Figure 4A), calculated assuming that dimers were the only
oligomerized species. To further confirm the high affinity for1328 Structure 23, 1325–1335, July 7, 2015 ª2015 Elsevier Ltd All rigdimerization of K-Ras4B1–166-GTP, we employed microscale
thermophoresis (MST) (Jerabek-Willemsen et al., 2011). The G
domain was labeled with fluorescein maleimide on Cys118. Sub-
stitution of this residue with Ser had no influence on Ras activity
(Mittar et al., 2004). Thus, we assume that addition of fluorescein
to this position might have an insignificant effect on dimerization.
We titrated the fluorescent protein with unlabeled GDP- or
GTP-g-S-loaded K-Ras4B1–166. For K-Ras4B1–166-GTP-g-S,
the KD is 1,180 ± 92 nM (Figure 4B). Although the addition of
K-Ras4B1–166-GDP is also accompanied by a change in thermo-
phoretic mobility of K-Ras4B1–166-GTP-g-S, the KD could not be
determined because the saturation could not be achieved due
to the limited solubility of the protein. The data suggest that a
‘‘heterodimer’’ is significantly less stable than a ‘‘homodimer’’
formed by K-Ras4B1–166-GTP-g-S. We detected the interaction
at concentrations of K-Ras4B1–166-GDP as low as 1 mM, which
could be physiological because membrane anchoring can
result in significant local concentrations of the Ras protein in
cells. While performing MST titration, we found that addition ofhts reserved
Figure 4. Biophysics of K-Ras4B Dimers
(A) Isothermal titration calorimetry (ITC) studies
of K-Ras4B1–166-GTP-g-S dimer dissociation. A
30-mMprotein solution was titrated into calorimeter
cell containing the buffer.
(B) Dissociation constant, KD, was determined by
microscale thermophoresis (MST) using 30 nM
K-Ras4B1–166-GTP-g-S labeled with fluorescein
maleimide on Cys118, which was mixed with
increasing concentrations of non-labeled protein.
(C) Addition of non-labeled K-Ras4B1–166-GTP-g-S
to fluorescein-labeled K-Ras4B1-166-GTP-g-S re-
sults in significant increase in fluorescence, which
was used for determination of KD. Concentration of
labeled protein was kept constant at 30 nM.
Error bars represent the standard error of three
measurements.non-fluorescent K-Ras to the fluorescent protein caused dra-
matic changes in the fluorescence of the fluorescein moiety
due to the changes in the dye environment. This change in fluo-
rescence allowed the determination of the binding KD by an
additional method (Figure 4C). The data further confirmed
high-affinity dimer formation. The discrepancy in KD values
obtained from MST and fluorescence studies (1,180 ± 92 nM
versus 2,530 ± 200 nM)may be due to the structural heterogene-
ity of the dimers, since different association modes will
have different impacts on the measured values resulting in
different combined effects and, thus, different apparent KD. To
evaluate the dimer configuration, we determined the distance
between fluorophores positioned on Cys118 residues of trun-
cated K-Ras4B1–166-GTP-g-S in the homodimer complex using
Fo¨rster resonance energy transfer (FRET). Fluorescein and tetra-
methylrhodamine were used for labeling K-Ras4B1–166-GTP-g-S
because this donor and acceptor FRET pair has been extensively
characterized. Addition of tetramethylrhodamine-labeled trun-
cated G domain caused an almost two-fold decrease in the fluo-
rescence of fluorescein-labeled GTP-g-S-loaded K-Ras4B1–166.
The energy transfer efficiency was calculated after corrections
for inner filter effect and changes in fluorescence outputs
due to changes in the environment of the fluorophore during
the dimerization. The determined efficiency was very high,
95.4% ± 5%. The calculations detailed in the Experimental Pro-
cedures indicate that the distance between the fluorophores in
the dimer is less than 39 A˚. This distance is in agreement with
the interfaces predicted by the computational studies, but
does not allow differentiation between them.
NMR Identification of K-Ras4B Dimerization Interfaces
To map the interfaces involved in the association of K-Ras4B
molecules in solution, we analyzed NMR chemical shift perturba-
tions (CSPs) induced by dilution of K-Ras4B samples. SampleStructure 23, 1325–1335, July 7, 2015dilution can cause dissociation of the pro-
tein-protein complexes and reveal the in-
terfaces by changes in the chemical shift
values. Earlier we observed that the HVR
associates with the catalytic domain of
K-Ras4B-GDP primarily via the high-affin-
ity b-sheet interface (data not shown),raising the possibility that this intramolecular interaction influ-
ences K-Ras4B dimerization. To address this possibility, we
studied the dimer interface of K-Ras4B1–166. We compared the
15N-labeled heteronuclear single quantum coherence (HSQC)
spectra of 245-mM and 30-mM K-Ras4B1–166-GTP-g-S (Fig-
ure 5A). These spectra show less line broadening and were
amenable to a more complete analysis. We had to use concen-
trations significantly higher than KD during spectra collection to
obtain sufficiently strong signals. However, the estimated con-
centration of the monomer at 30 mM total K-Ras concentration
is 4 mM, which is capable of generating detectable signals. Res-
idues that exhibited dilution-dependent CSPs include K16 and
I24 in a1, D30, E31, and E37 in the Switch I region, and S39 and
V44 in b2 (Figure 5B; Figure S5A). In addition, we observed signif-
icant changes in N86 in a3, D119 in the G4 loop, Q131 and R135
in a4, and K147 in the G5 loop. Next, we measured the changes
in 15N-HSQCspectra of high (200mM)and low (18mM)concentra-
tions of K-Ras4B1–188-GTP-g-S. Spectral overlays demonstrated
CSPs caused by sample dilution (Figure 5C); however, significant
line broadening due to conformational fluctuations and protein-
protein interactions prevented observation of many resonances
in the GTP-g-S-bound protein. Residues exhibiting significant
CSPs were scattered: A18 in a1, D38 in the Switch I, I84 in b4,
E91 in a3, V114 in b5, V125 in the G4 loop, A130 in a4, E143 in
b6, and Y157 in a5 regions (Figure 5D; Figure S5B). Although
the dilution-induced CSPs in GTP-g-S-loaded full-length and
truncated K-Ras4B are not identical, the involvement of a1,
Switch I, a3, G4 loop, a4, and G5 loop can be observed in both.
TheHVRmight also engage b4,b5,b6, and theN-terminal portion
of a5 in K-Ras4B-GTP-g-S dimerization.
Residues with large chemical shift changes are mainly located
at the N-terminal effector lobe of the G domain (Figures 5A and
5B; Figure S5A), in good agreement with the predictions (Fig-
ure 6). Of the residues showing large chemical shift changes,ª2015 Elsevier Ltd All rights reserved 1329
Figure 5. NMR Chemical Shift Perturbations
of Residues in the GTP-bound K-Ras4B
Dimer
(A) An overlay of high (blue) and low (red) concen-
trations of 15N-HSQC NMR spectra of truncated
K-Ras4B1–166-GTP-g-S (245 and 30 mM). Exam-
ples of chemical shift changes are marked with
arrows.
(B) The perturbed residues of K-Ras4B1–166-GTP-
g-S are mapped on the catalytic domain structure
of GTP-bound K-Ras4B.
(C) An overlay of high (blue) and low (red) concen-
trations of 15N-HSQC NMR spectra of full-length
K-Ras4B1–188-GTP-g-S (200 and 18 mM). Exam-
ples of chemical shift changes are marked with
arrows.
(D) The perturbed residues of K-Ras4B1–188-GTP-
g-S are mapped on the catalytic domain structure
of GTP-bound K-Ras4B.57% are identical with those predicted by computations and
29% are located adjacent to the predicted interface residues.
Those residues located at the C-terminal allosteric lobe can
serve as the second major binding interface, as predicted by
computations (Figure 3B; Table S6). Two of the five perturbed
residues, Q131 and R135 in a4, correlate with our prediction.
Taken together, these results indicate that the chemical shift
perturbation data agree well with the predicted binding sites.
For the GDP-bound state, we used high (275 mM) and low
(30 mM) concentrations of K-Ras4B1–166-GDP. The spectral
overlays demonstrate significant structural differences (Fig-
ure S6A). Most CSPs concentrate in only five residues, E3 in
b1, F28, and D38 in the Switch I region, H94 in a3, and Q129 in
a4 (Figure S6B). Spectral overlays of 15N-HSQC spectra of
780- and 50-mM K-Ras4B1–188-GDP indicated dilution-associ-
ated chemical shift changes (Figure S7A). Most CSPs concen-
trate in the b2 (K42, I46, E49, C51-L53), a2 (M72 and G75), b4
(V81 and N85), and a3 (K88, I93, I100) regions (Figure S7B).
The CSPs also indicate potential involvement of E3 in b1, D38
in the Switch I region, and Q150 in the G5 loop regions. More
extensive interfaces were found for K-Ras4B1–188-GDP, sug-
gesting a role for HVR in K-Ras4B-GDP dimerization.
Ras-Effector Binding and Tetramerization
Comparison of crystal structures of Ras with its effectors (Raf,
PI3K, and RalGDS) show that the predictedmajor b-sheet exten-1330 Structure 23, 1325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reservedsion dimer interface (Figure 7A) overlaps
the binding site of the effectors. Structural
analysis revealed that the binding sur-
faces and interaction modes of Raf (Fig-
ures 7B and 7C; Table S8) and other Ras
effectors, important in cell transformation
and proliferation such as PI3K (Figure 7D),
PLCε, Byr2, and Nore1A (crystal struc-
tures of the complexes of these effectors
bound to Ras are available), and Cdc42
and Ftase (crystal structures of these
Ras regulators are not available, but the
complexes are predicted by PRISM),overlap the Ras b-sheet dimer interface; RalGDS (crystal
structure, Figure 7E), IMPA1 (predicted), and RIN1 and RassF1
(structures modeled and interfaces predicted) partially overlap.
Overlapping (or partially overlapping) interfaces argue for an
effective local effector concentration threshold as a regulatory
mechanism in activation and signaling. Computations also pre-
dict a major helical interface at a3/a4 (Figure 3B), supported by
NMR chemical shift experiments for homo K-Ras4B-GTP (Fig-
ure S5) and hetero K-Ras4B-GTP/K-Ras4B-GDP (Figure S8)
dimers. Ras regulators, PKCa (crystal), RAIN, RGS12, AFAD
(structure modeled and interface predicted) overlap these inter-
faces, and RGL1 (modeled and predicted) partially overlaps.
Finally, DLS data suggest higher-order tetramer organization in
the full-length protein (Figure 2B).We did not detect tetramer for-
mation by the G domain, suggesting that any pairs of non-over-
lapping interfaces are unlikely to allow for tetramer formation
in the absence of the HVR. However, the HVR facilitates
tetramerization even in the absence of the membrane. Three
types of dimers and the higher-order tetrameric organizations
further affirm nanocluster formation. Our interface predictions
supported by NMR data suggest that themajor nanocluster spe-
cies is Ras-GTP, in good agreement with experimental data
(Plowman et al., 2005). Since effector binding overlaps the
dimeric interfaces, dynamic cluster reorganization can be ex-
pected. For dimeric Raf, nanoclusters can also be networked
via the Raf catalytic domain.
Figure 6. Comparison of NMR Chemical Shift Data with Computa-
tional Predictions
Mappings of residues from NMR chemical shift perturbations (CSPs) results
for K-Ras4B-GTP-g-S (Figure S5A) (red and orange sticks) and the predicted
residues in the dimer interface by computations for K-Ras4B-GTP b homo-
dimer (as in Figure 3A) (dark blue sticks) and a homodimer (as in Figure 3B)
(light blue sticks). Yellow sticks enclosed by transparent surface represent the
common residues from both NMR and computations.DISCUSSION
Ras dimerization and higher oligomerization states were long
believed to increase signaling output and facilitate interactions
with effectors, such as Raf (Guldenhaupt et al., 2012; Inouye
et al., 2000; Kolch, 2000). However, dimerization was not
observed in soluble Ras, leading to an assumption that inter-
faces observed in crystals were due to crystal packing interac-
tions. DLS studies have unexpectedly revealed GTP-dependent
dimerization of the K-Ras G domain, which we further confirmed
byMST, ITC, fluorescence spectroscopy, FRET, NMR spectros-
copy, and computational analysis. Application of a powerful
structural prediction algorithm confirmed high-affinity homo-
dimer formation for K-Ras4B-GTP, but only low-affinity dimer-
ization for K-Ras4B-GDP. A survey of Ras crystal structures
showed that while the functional state of Ras has been identified
as a monomer, its predicted membrane-anchored dimeric inter-
face is among its crystal packing interactions (Figure S2). Dilu-
tion-induced NMR CSPs of K-Ras4B1–188 and K-Ras4B1–166
dimers further identify dimer interfaces. Both suggest a highly
dynamic K-Ras self-association that is likely to involve more
than a single interface. Remarkably, the structural elements
involved in the dimer interactions predicted by the computations
are in good agreement with those detected by NMR (Figure 3);
the predictions cover 50% of all the interface residues identified
by chemical shift changes. The most stable dimer interface is
located at a1, b2, and b3, including the Switch I and effector
binding regions. Although the helical dimer interface appears
less populated for the G domain, the relative populations of
the interfaces may change in full-length membrane-anchored
K-Ras4B.
The dimerization of N-Ras and H-Ras underscore the impor-
tance of the plasma membrane for Ras association (Gulden-
haupt et al., 2012; Lin et al., 2014). Farnesylated and methylated
synthetic HVR of K-Ras4B tends to aggregate at concentrations
as low as 5–10 mM (Chavan et al., 2013) and thus can significantly
enhance dimerization. Our results demonstrate that K-Ras di-Structure 23, 1mers can also form in solution; however, the measured relatively
high dimer dissociation constants suggest that to dimerize, the
concentration of K-Ras has to be high. The plasma membrane
may act to increase the effective local concentration of K-Ras.
This is in agreement with previous observations indicating that
the requirement of the plasma membrane for Ras dimerization
and ability to activate Raf can be overcome by a GST fusion
tag that increases the affinity of Ras monomers toward each
other (Inouye et al., 2000). Expression levels and the activation
state of partners can also affect dimerization. The range of crys-
tal dimer interfaces observed in different crystal forms captures
snapshots of heterogeneous dimer conformations. Interfaces,
including those of Ras dimers, are dynamic, interconverting be-
tween substates (Aramini et al., 2014). Along these lines, a large-
amplitude rocking motion has been detected by 19F-NMR in the
dimer interface of influenza A virus nonstructural protein 1 (Ara-
mini et al., 2014). We propose that both a-helical and b-sheet
dimers are populated in membrane nanoclusters; a single inter-
face type is unlikely to support nanocluster avidity.
It is remarkable that K-Ras4B1–166 loaded with the non-hydro-
lyzable GTP analog GppNHp showed a greatly reduced
tendency to dimerize compared with the protein loaded with
GTP-g-S. This high sensitivity to the nucleotide analog structure
may explain why Ras dimerization was not previously observed
in solution (Guldenhaupt et al., 2012; Lin et al., 2014): GppNHp is
the most commonly used GTP analog, due to its chemical stabil-
ity, and was used in all earlier studies. However, recent data sug-
gest that it is a poorer mimetic of GTP compared with GTP-g-S
(Spoerner et al., 2010). GTP-g-S, on the other hand, undergoes
not only catalyzed, but also spontaneous hydrolysis, which
makes its use in traditional but slow methods of oligomerization
analysis such as size-exclusion chromatography and ultracentri-
fugation, impractical. The ability of GppNHp to induce a GDP-
like state has also been detected in other GTPases (Paleskava
et al., 2012). The observed difference in the ability to induce
Ras dimerization between two GTP analogs, GTP-g-S and
GppNHp, along with reported data on their effects on Ras
conformation and dynamics, correlate well with the predicted
mechanisms of dimer formation. The affinity toward Ras varies
significantly among the RBDs of effectors, and some have KD
comparable with that of Ras dimerization. We do not observe a
significant presence of trimers and tetramers of the G domain
in solution. However, supported by experimental data, we
observe computationally that K-Ras4B can form K-Ras4B-
GTP/K-Ras4B-GDP heterodimers at the same interface (Fig-
ure S4A). This is expected: this region is populated by effectors
via b-sheet extension, also a structural property of K-Ras4B-
GDP. Furthermore, the NMR CSP cluster between T20 and
M67 (Figure S8) fits our main predicted interface (heterodimer 1
with BES = 45.66), and the cluster between V125 and
D154 fits the second interface prediction (heterodimer 2 with
BES = 33.25).
Oligomerization enhances cooperativity, and the dimerization
interfaces are also involved in binding the effectors. Thus, the
major raison d’eˆtre of the oligomerization could be higher spec-
ificity among Ras isoforms by restricting binding events and
averting redundant signaling. The Ras tetramer landscape is het-
erogeneous, can be nucleotide dependent, and can shift with
the effector concentrations, isoform sequence, and membrane325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1331
Figure 7. Ras-Effector Binding
(A) Side-by-side comparisons of the predicted
b-sheet interface of K-Ras4B-GTP b homodimer
(as in Figure 3A) with interfaces observed in crystal
structures of Ras effectors.
(B and C) Predicted dimer structures of the GTP-
bound K-Ras4Bwith (B) Ras-binding domain (RBD)
of Raf1 (target PDB: 1C1Y; template interface:
1c1yAB) and (C) RBD of B-Raf (target PDB: 3NY5;
template interface: 1c1yAB).
(D and E) Crystal dimer structures of (D) H-Ras
(G12V) with PI3Kg (PDB: 1LHE8) and (E) H-Ras
(E31K) with Ras-interacting-domain (RID) of
RalGDS (PDB: 1LFD).
Arrows indicate the same b-sheet extension motif
in the homodimer and in Ras-effector (Raf, PI3K,
and RalGDS) crystal structure complexes.environment, resulting in preferred orientation with respect to the
membrane (Abankwa et al., 2010; Jang et al., 2015). In a similar
vein, EphA isoforms assemble into different crystal organizations
for distinct functions (Himanen et al., 2010; Seiradake et al.,
2013), with a single mutation converting a circular architecture
to an extended one with a concomitant functional change. Along
these lines, the varied structures of the allosteric lobe across Ras
isoforms suggest that they may populate different dimerization
(and higher oligomerization) states; thus, our minor (a and b)
dimeric interface species, which are sparsely populated in
K-Ras4B, may be highly populated in N- or H-Ras. Together
with the different HVR sequences and preferredmembrane inter-
action domains, they may result in isoform-specific signaling
from the membrane.
The dimer interfaces described here suggest a paradigm
shift in Ras-effector activation. The common view holds that
Ras dimerization is involved in Raf activation, with each Ras
monomer able to simultaneously dimerize and interact with
the Raf RBD; however, the Ras homo-/heterodimer b inter-
face is almost identical to that involved in Ras binding to Raf,
PLCε, PI3K, Ftase, and CDC42. The helical interfaces are
involved in Ras binding to PKCa, TIAM, and possibly other
effectors. The emerging scenario paints a dynamic landscape
populated by b-sheet- and helical-interface-mediated dimers
that associate further into nanoclusters. Shared interfaces
imply Ras oligomerization dependence on the effectors. This
is supported by the observed enhancement of K- and N-Ras
nanoclustering by B-Raf inhibition (Cho et al., 2012). Raf, with
nanomolar affinity for Ras, outcompetes the b-sheet-mediated
dimerization. Raf dimerization may be enhanced via self-
association of membrane-anchored Ras through the helical
interfaces (Figure 8). Dimerization can prevent external stimuli1332 Structure 23, 1325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reservedfrom causing repetitive cellular firing.
We reason that tetramerization driven
by farnesylated K-Ras4B on the inner
plasma membrane via dynamic, concen-
tration- and actin-dependent (Plowman
et al., 2005) associations, through galec-
tin and possibly IQGAP1 (Nussinov et al.,
2013; Osman et al., 2013), confers
higher specificity and cellular control.Dimerization may further induce higher selectivity across Ras
isoforms through preferred orientation of interaction with the
membrane.
To conclude, a powerful combination of four interdisciplinary
techniques allowed us to elucidate the structural basis of Ras
dimerization. The results reveal a complex mechanism of down-
stream signaling regulation by Ras oligomerization that involves
cooperativity and selectivity through shared binding interfaces.
Our results argue that therapeutically abolishing the major
b-sheet-mediated dimerization may not deter the activation of
Raf; however, the helical dimer interfacemay be targeted by syn-
thetic compounds to abate Raf signaling in cancer. The shape
and stability of Ras as a monomer argue that it can function
and activate the effectors as amonomer. The emergence of mul-
tiple dimer interfaces affirms the significance of nanoclustering in
the regulation of activation and signaling of Ras effectors (Nussi-
nov, 2013).
EXPERIMENTAL PROCEDURES
Computational Prediction of the Ras Dimer Structures
In this study, we used PRISM (Aytuna et al., 2005; Ogmen et al., 2005;
Tuncbag et al., 2011), a template-based protein-protein complex structure
prediction algorithm, to predict models for the dimeric structures of the
Ras protein. PRISM is based on our observation that protein-protein inter-
face motifs are conserved in nature, similar to single-chain architectures
(Keskin et al., 2004, 2008; Tsai et al., 1996). PRISM uses the tertiary structure
of proteins of interest to build models. The solutions are optimized by a
docking refinement protocol and ranked based on the BES computed by
FiberDock (Mashiach et al., 2010), which has been implemented in
PRISM. PRISM has been tested extensively for a range of proteins and
pathways (Tuncbag et al., 2012). The structural data for the dimer predic-
tions (target proteins) have been obtained from the PDB. We used the G
domains (corresponding to Ras residues 4–166) of both H- and K-Ras as
Figure 8. Ras Dimerization and Raf Activation
Cartoons represent (A) Ras dimerization and (B) Ras-Raf binding in the cell
membrane.target proteins. K- and H-Ras catalytic domains have 10 and 115 struc-
tures, respectively, in the PDB. We included all K-Ras structures in the
prediction (Table S1). For H-Ras, only X-ray structures with resolution of
2.00 A˚ or lower were considered. To reduce the redundancy due to very
similar interface architectures, we calculated the RMSD for each pair. For
structures with RMSD below 0.25 A˚, we chose a representative with the
highest resolution. In this way, the number of structures for H-Ras was
reduced to 46 (Table S1). Then we identified the interface regions of the
putative dimers using the HotPoint web server (Tuncbag et al., 2010), which
accounts for conservation, solvent accessibility, and the total contact poten-
tial of the interface residues. We compared our results with crystal structures
to further affirm our predictions. We used the EPPIC (Duarte et al., 2012)
server to classify the crystal interfaces in Ras structures. We further built
unit cells of Ras crystals using Chimera to check whether the interfaces
matched.
Protein Preparation
Protein preparation was carried out according to our previously published pro-
tocol (Abraham et al., 2010). K-Ras4B cDNA (full-length and catalytic domain)
from Invitrogen was cloned into the pET42a vector (Novagen). Full details are
provided in the Supplemental Experimental Procedures.Structure 23, 1Dynamic Light Scattering
DLS studies were performed on a DynaPro Tytan instrument equipped with a
Temperature-Controlled MicroSampler (Wyatt Technology) at a laser wave-
length of 830 nm and scattering angle of 90, in a 12-ml quartz cuvette at
25C. Each measurement consisted of sixty 10-s acquisitions. All samples
were centrifuged at 15,000 g for 10 min before measurements. To obtain the
hydrodynamic radii (Rh) and percentage polydispersity, the intensity autocor-
relation functions were fitted with a non-negative least-squares algorithm by
Dynamics 7.1.1.3 software (Wyatt Technology).
Isothermal Titration Calorimetry
The dissociation process was studied using an isothermal titration microcalo-
rimeter iTC200 (GE Healthcare/Microcal) at 25
C. The typical experiment
included injection of ten aliquots (3.0 ml each) of 30–70 mM K-Ras protein
solution into buffer in the ITC cell (volume 200 ml). The buffer used was
collected during the size-exclusion chromatography purification of the protein;
therefore, its composition exactly matched the buffer of the protein solution.
After filling the syringe with the solution, the level at the tip of the syringe
was thoroughly adjusted to eliminate an air bubble that could affect the preci-
sion of the first injection. The experiments were run at ‘‘High feedback mode/
gain’’ setting. The stirring speed was 1,000 rpm. The duration of the injection in
seconds was usually twice the value of injection volume. The integrated heat
values were fit using the Origin 7.0-based ITC data analysis software provided
by GE Healthcare/MicroCal. If necessary, prior to the integration procedures
the baseline was manually adjusted to minimize the background noise. The
model ‘‘Dissociation’’ was used as the basic option, yielding the dissociation
constant KD and other thermodynamic parameters.
Microscale Thermophoresis
For labeling the Ras protein with fluorescein, 1.6 mg fluorescein maleimide
(Santa Cruz Biotechnology) was dissolved in 25 ml DMSO; 5 ml was diluted in
10 ml buffer. The resulting solution was slowly added to 400 ml of 75 mM
GTP-g-S-loaded K-Ras solution in 100 mM HEPES buffer (pH 6.5) containing
5 mM MgCl2, 50 mM NaCl, and 0.5 M tris(2-carboxyethyl)phosphine. The
mixture was incubated overnight at 4C and filtered through an NP-5 column
(GE Healthcare) equilibrated with the reaction buffer. Liquid chromatography-
mass spectrometry showed no traces of the maleimide and complete labeling
of intact K-Ras. For MST studies we prepared 16 two-fold serial dilutions of
GDP- or GTP-g-S-loaded K-Ras1–166 starting from 60 mM. Titration series
were prepared that contained 15 ml of 60 nM fluorescein-labeled K-Ras and
15 ml of non-labeled K-Ras. The final buffer composition included 25 mM
HEPES (pH 7.2), 50 mM NaCl, and 2.5 mM MgCl2. MST measurements were
taken in standard treated capillaries on a Monolith NT.115 instrument
(NanoTemper Technologies) using 50% infrared laser power and LED excita-
tion source with l = 470 nm. NanoTemper Analysis 1.2.20 software was used
to fit the data and determine the KD values.
Fo¨rster Resonance Energy Transfer
Full details of the FRET method are provided in Supplemental Experimental
Procedures.
NMR Experiments
All 1H,15N-HSQC NMR spectra were collected on a 900-MHz Bruker Avance
Spectrometer at 25C. The buffer used for dissolving the proteins contained
50 mM Tris-citrate (pH 6.5), 50 mM NaCl, 5 mM MgCl2, 10 mM b-mercaptoe-
thanol, 10mMCaCl2, and10%deuteratedwater. Data processing andanalysis
were carried out using NMRPipe. The Biological Magnetic Resonance Data
Bank (BMRB) database (http://www.bmrb.wisc.edu) was used for chemical
shift assignments (BMRB: 17785 and 18529). HNCA, HNCB, and CBCACOHN
experiments were used to make assignments for the hypervariable region
domain. For probing the CSPs, the mean chemical shifts were calculated by
DdNH =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DdNH
2
+ ðDdNÞ2
.
25
2
vuut
:
As per convention, CSPs higher than the sum of the average and one SD
were considered to be statistically significant. The figure legends note the con-
centrations of the proteins used in each experiment.325–1335, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1333
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